Hahnemann Sneezing
FDA Label NDC 63545-646

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hahnemann Laboratories, Inc. Dba Alpine Pharmaceuticals for the product Hahnemann Sneezing (NDC 63545-646). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, keep out of reach of children, use, warnings, directions, inactive ingredients, package label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

ACTIVE INGREDIENT listed above

GLYCERINUM

Purpose

SNEEZING

Keep Out Of Reach Of Children

Keep out of reach of children.

Use

USE according to standard Homeopathic indications for self-limiting conditions, such as listed above. SNEEZING

Warnings

Warning: If pregnant, nursing, or if symptoms persist consult your practitioner.

Directions

DIRECTIONS: Dissolve one dose under tongue. Repeat as needed or as directed. Stop taking if symptoms worsen.

DOSE: Adults and children take 10 -15 pellets once or as directed by your prescriber.

Inactive Ingredients

INACTIVE INGREDIENTS: sucrose. lactose

Package Label

GLYCERINUM   200C SNEEZING  EST 63545   Contains 5g

HOMEOPATHIC MEDICINE

Hahnemann Laboratories Inc. 1940 Fourth St. San Rafael, CA 94901

TWIST TO OPEN-USE ONLY IF SEALED

QUESTIONS: Toll free 888-427-6422

Hahnemann Sneezing (Hanmemann Sneezing)

Hahnemann Sneezing (Hanmemann Sneezing)

* Please review the disclaimer below.